
Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS). Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS).
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.01 | -8.77497827976 | 11.51 | 12 | 11.16 | 3902 | 11.68601244 | CS |
4 | -0.92 | -8.05604203152 | 11.42 | 12.5499 | 10.31 | 8537 | 11.48806675 | CS |
12 | -1.91 | -15.3908138598 | 12.41 | 18.17 | 9.5 | 30743 | 12.9222086 | CS |
26 | 2.37 | 29.1512915129 | 8.13 | 18.17 | 7.5 | 31308 | 11.51088305 | CS |
52 | -2.75 | -20.7547169811 | 13.25 | 18.17 | 5.9999 | 22057 | 11.040062 | CS |
156 | -39.9 | -79.1666666667 | 50.4 | 55.95 | 4.5 | 141842 | 11.22732777 | CS |
260 | -132.75 | -92.6701570681 | 143.25 | 210 | 4.5 | 142481 | 30.39901482 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.